Mount Manaslu base camp fell in the grip of an avalanche, 7 days ago also a destructive avalanche
Ukraine: Owner’s family members died in missile attack, then dog cried sitting on rubble of house; watch the video
Left China and India, this American actor became the father of
"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."
Cureus is on a mission to change the long-standing paradigm of medical publishing, where submitting research can be costly, complex and time-consuming.
Please log in, or sign up for a new account and purchase a subscription to continue reading.
Please log in, or sign up for a new account to continue reading.
Thank you for reading! We hope that you continue to enjoy our free content.
Cloudy skies early will become partly
The RECOVER IV trial is a two-arm study that seeks to analyze whether percutaneous coronary intervention (PCI) with Impella® heart pumps used prior to PCI is superior to PCI without Impella support.
In this video interview, Drs. Nick Smith (Johns Hopkins Hospital) and Gurleen Kaur (Brig
August 16, 2022 09:00 ET | Source: Medi-Tech Insights Medi-Tech Insights
BRUSSELS, BELGIUM, Aug. 16, 2022 (GLOBE NEWSWIRE) --
Co
September 09, 2022 07:23 ET | Source: Research and Markets Research and Markets
Dublin, Sept. 09, 2022 (GLOBE NEWSWIRE) -- The "Global Ur
"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."
Cureus is on a mission to change the long-standing paradigm of medical publishing, where submitting research can be costly, complex and time-consuming.
‘Changes to the NMC’s English language requirements are a victory for common sense’
Intermittent catheters shouldn’t be sticky, uncomfortable or messy. Discover FeelCleanTM Technology for a more comfortable user experience.
The experience of performing self-catheterisation
Bentley today announced that it has acquired the rights of the GoBack catheter from Upstream Peripheral Technologies.
“The acquisition of the GoBack catheter marks the start of inorganic growth for Bentley,” said Sebastian Büchert, Bentley’s CEO. “We launched our first of si
We use cookies to enhance your experience. By continuing to browse this site you agree to our use of cookies. More info.
A device known as the BASHIR™ Endovascular Catheter (THROMBOLEX, Inc.) significantly red